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G3+ GU toxicity was observed in 1% of DE-EBRT and 2.5 % of 
LDR-PB arms. No acute G3+ GI toxicity was observed. The 
cumulative incidence of late G3+ GU toxicity at 2 and 6 years 
was 4% and 8% in DE-EBRT versus 8% and 18% LDR-PB 
respectively (p<0.0001). Urethral strictures requiring 
dilatation, urinary retention requiring a TURP or TUIP, and 
severe urinary incontinence were the most common G3+ GU 
events and were all significantly less common with DE-EBRT 
at 1%, 1% and 0% compared to LDR-PB at 7.5%, 3%, and 2.5%. 
The prevalence of G3+ GU toxicity at 2 and 6 years with DE-
EBRT was 1.6% and 1.1% versus 5.4% and 4.7% with LDR-PB. 
The cumulative incidence of late G3+ GI toxicity at 2 and 6 
years was 3% and 4% with DE-EBRT versus 3% and 9% with 
LDR-PB respectively (p=0.07). Grade 3 rectal bleeding and 
fecal incontinence were observed in 3.5% and 0% of DE-EBRT 
patients versus 3.0% and 1.5% with LDR-PB. The prevalence of 
G3+ GI toxicity at 2 and 6 years with DE-EBRT was 2% and 0% 
versus 1.0% and 0% with LDR-PB. 
 
Conclusions: GI toxicity did not differ significantly between 
arms, but the cumulative incidence of late G3+ GU toxicity 
was 18% with LDR-PB versus 8% with DE-EBRT. Since many 
toxicity events were temporary and others were reversed or 
ameliorated by urologic procedures, the long term 
prevalence of G3+ GU toxicity with LDR-PB is much lower 
than the incidence rate. 
*ASCENDE-RT- Androgen Suppression Combined with Elective 
Nodal and Dose Escalated Radiation Therapy is an NCI 
registered trial (NCT00175396). 
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Purpose/Objective: Modern diagnostic imaging gives high-
resolution anatomical detail enabling detection of tumour 
deposits measuring only a few millimetres. As a consequence, 
it is plausible that the occult tumour-load in what we 
currently identify as the 'elective volume' is much less than 
before. Therefore, dose reduction to elective lymph node 
regions is increasingly becoming a topic of interest in 
radiation therapy (RT) for head and neck cancer, in order to 
reduce acute and late radiation sequelae. The aim of this 
study is to provide insight in patterns of recurrence in 
electively irradiated lymph node regions after intensity-
modulated radiation therapy (IMRT) for head and neck 
cancer. 
Materials and Methods: A total of 264 patients having stage 
cT2-4N0-2M0 squamous cell carcinoma of the oropharynx, larynx 
or hypopharynx treated with curative intent using 
accelerated IMRT between 2008-2011 were included. 
Excluded were patients treated with surgery or 
chemotherapy. Median follow-up is 2.7 years. RT planning 
CT-scans from all patients were reviewed and all lymph 
nodes (short -axis diameter ≥5mm and ≤10mm) localized in 
the elective volume were identified and delineated. For each 
node, we measured volume, long- and short-axis diameter. 
The exact sites of regional recurrences were reconstructed 
and projected on the initial RT treatment planning CT-scan 
by performing co-registration with diagnostic imaging of the 
recurrence. 
Results: Actuarial rate of recurrence in electively irradiated 
lymph node regions was 5.1% (95% CI:2.4-7.8%) at 2 years.  
On the RT planning CT-scans, 1166 electively irradiated 
lymph nodes (short -axis diameter ≥5mm and ≤10mm) were 
identified. Volumetric analysis showed an increased risk of 
recurrence with increasing nodal volume, up to 19.4% (95% 
CI:5.1-33.7%) at 3 years for lymph nodes >1.5cc. The summed 
long- and short-axis diameter showed to be a pragmatic 
alternative for the more laborious volume calculations, 
having an optimal combination of sensitivity (88%) and 
specificity (79%) when setting the cut-off to ≥17mm (figure 
1). 
 
 
 
Figure 1: Recurrence in electively irradiated lymph nodes 
according to summed short- and long-axis diameter 
Univariate analysis: <17mm versus ≥17mm (p<0.001)  
Conclusions: This is the first study focussing on recurrences 
in electively irradiated lymph nodes in a large and 
homogeneous population after definitive IMRT. Important 
risk-factors were identified that can help clinicians in the 
pre-treatment risk-assessment of borderline-sized lymph 
nodes. Not overtly pathologic lymph nodes having a summed 
diameter ≥17mm may require an intermediate RT dose. For 
low-risk elective areas (all nodes <17mm), de-escalation 
below the traditional 50Gy can be considered.  
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